Day: February 7, 2023

TEMECULA, Californie, 07 févr. 2023 (GLOBE NEWSWIRE) — Nikkiso Clean Energy & Industrial Gases Group (le « Groupe »), qui fait partie de Nikkiso Co., Ltd (Japon), opérant sous Cryogenic Industries, Inc. (État-Unis d’Amérique), a finalisé l’acquisition de la société Cryotec Anlagenbau GmbH (Cryotec), située à Wurzen, Saxe, Allemagne. Le montant n’a pas été divulgué.

Société opérant dans l’ingénierie et la construction d’installations à l’échelle mondiale, Cryotec fournit des services de planification, gestion de projets, fabrication et ingénierie d’installations de liquéfaction et de séparation de l’air conteneurisées/montées sur plateforme, ainsi que des technologies axées sur le CO2 offrant des solutions personnalisées à ses clients.

Cryotec opèrera dans le cadre de l’installation GmbH du Groupe, basée à Neuchâtel-sur-le-Rhin, en Allemagne.

Le Groupe se compose de six unités commerciales fonctionnelles : Pompes cryogéniques, Systèmes d’échangeur de chaleur, Systèmes de processus, Ravitaillement et Solutions, Infrastructure énergétique et Service et projets stratégiques. Cryotec fera office de centre de compétence et de production de Nikkiso Clean Energy & Industrial Gases Group en Europe.

« Nikkiso fera la promotion et la vente à l’échelle mondiale des solutions packagées intelligentes de Cryotec, qui réduisent et récupèrent les émissions de dioxyde de carbone et soutiennent davantage les objectifs de durabilité du Groupe. Cryotec disposera d’un accès complet aux technologies innovantes développées en Californie et ailleurs dans le Groupe Nikkiso et proposera des packages, des solutions et des stations localisés pour le LH2 (hydrogène liquide), le GNL (gaz naturel liquéfié), l’ammoniac et les applications de stockage d’énergie cryogénique en Allemagne et en Europe. Nous soutiendrons la croissance de Cryotec, en ajoutant des ressources et en accroissant nos activités de fabrication et d’assemblage en Saxe et en apportant des solutions Cryotec à l’Allemagne et au marché mondial », a déclaré Peter Wagner, PDG de Cryogenic Industries et président du Groupe.

Le ministre-président de Saxe, Michael Kretschmer, a déclaré : « L’acquisition de Cryotec Anlagenbau par Nikkiso renforce l’internationalisation d’une société traditionnelle de Wurzen, en Saxe. Nikkiso détient une expérience mondiale dans l’énergie renouvelable, l’hydrogène et le stockage d’énergie. Les énergies renouvelables et l’hydrogène vert jouent un rôle prédominant pour atteindre les objectifs énergétiques et climatiques en Saxe. L’État libre de Saxe est déjà un lieu important pour la recherche et l’application des technologies de l’hydrogène. Je suis ravi que Nikkiso apporte à l’avenir son expertise à la Saxe. »

« Nikkiso sera en mesure d’aider à la réalisation du projet ainsi qu’à la fourniture et à l’entretien de stations de remplissage d’hydrogène liquide et de GNL sur le marché européen », selon Ole Jensen, vice-président, Europe. « Cette acquisition représente notre engagement et notre soutien envers les objectifs de l’Union européenne pour devenir climatiquement neutres d’ici 2050. »

L’acquisition est entrée en vigueur le 3 février 2023.

À PROPOS DE Nikkiso Clean Energy & Industrial Gases Group
Nikkiso Clean Energy & Industrial Gases Group fait partie de la division industrielle de Nikkiso Co., Ltd. Japon. Le Groupe opère aux États-Unis, sous Cryogenic Industries, Inc. (un membre de Nikkiso Co., Ltd.). Les entreprises membres du Groupe fabriquent et entretiennent des équipements de traitement du gaz cryogénique (pompes, turbo-détendeurs, échangeurs thermiques, etc.), et des usines de traitement pour les gaz industriels, la liquéfaction du gaz naturel (GNL), la liquéfaction de l’hydrogène (LH2) et le cycle organique de Rankine pour la récupération de la chaleur perdue. Fondée il y a plus de 50 ans, Cryogenic Industries est la société-mère d’ACD, de Nikkiso Cryo, de Nikkiso Integrated Cryogenic Solutions, de Cosmodyne et de Cryoquip, et d’un groupe administré en commun comptant une vingtaine d’entités opérationnelles.

Pour tout complément d’information, veuillez consulter les sites www.NikkisoCEIG.com et www.nikkiso.com.

Contact auprès des médias :
Anna Quigley
+1.951.383.3314
aquigley@cryoind.com

Une photo accompagnant ce communiqué de presse est disponible à l’adresse https://www.globenewswire.com/NewsRoom/AttachmentNg/5818ee3c-2c93-4ad0-b03b-a87bda21cfce

GlobeNewswire Distribution ID 8744074

TEMECULA, Califórnia, Feb. 07, 2023 (GLOBE NEWSWIRE) — O Clean Energy and Industrial Gases Group (“Grupo”) da Nikkiso Cryogenic parte da Nikkiso Co., Ltd (Japão), operando sob a Cryogenic Industries, Inc. (EUA), finalizou a aquisição da Cryotec Anlagenbau GmbH (Cryotec), de Wurzen, Saxônia, Alemanha por um valor não revelado.

Uma empresa global de engenharia e construção de plantas, a Cryotec fornece serviços de planejamento, gerenciamento de projetos, fabricação e engenharia de plantas de separação e liquefação de ar montadas em skid/em contêineres e tecnologias de CO2 que oferecem soluções personalizadas para seus clientes.

A Cryotec será operada como parte das instalações da GmbH do Grupo, com sede em Neuenburg am Rhine, Alemanha.

O Grupo é composto por seis unidades funcionais de negócios: Bombas Criogênicas, Sistemas de Troca de Calor, Sistemas de Processo, Abastecimento e Soluções, Infraestrutura de Energia, e Projetos e Serviços Estratégicos. A Cryotec atuará como o centro de competência e produção do Nikkiso Clean Energy and Industrial Gases Group na Europa.

A Nikkiso promoverá e venderá globalmente os pacotes de soluções inteligentes da Cryotec que reduzem e recuperam as emissões de dióxido de carbono e apoiam ainda mais as metas de sustentabilidade do Grupo. A Cryotec terá acesso total às tecnologias inovadoras do Grupo Nikkiso desenvolvidas na Califórnia e em outros lugares, e oferecerá pacotes, soluções e estações localizadas para LH2 (Hidrogênio Líquido) LNG (Gás Natural Liquefeito), amônia e aplicações de armazenamento de energia criogênica na Alemanha e na Europa. Daremos suporte ao crescimento da Cryotec, com mais recursos e aumento das nossas atividades de fabricação e montagem na Saxônia, e com o fornecimento de soluções Cryotec na Alemanha e no mercado global”, disse Peter Wagner, CEO da Cryogenic Industries e Presidente do Grupo.

O Primeiro-Ministro da Saxônia, Michael Kretschmer, disse: “A aquisição da Cryotec Anlagenbau pela Nikkiso fortalece a globalização de uma empresa saxã tradicional de Wurzen. A Nikkiso tem experiência global em energia renovável, hidrogênio e armazenamento de energia. As energias renováveis e o hidrogênio verde têm um papel fundamental no atingimento das metas energéticas e climáticas na Saxônia. A Saxônia já é um local importante para a pesquisa e aplicação de tecnologias de hidrogênio. Estou muito contente com a contribuição da Nikkiso com sua experiência para a Saxônia no futuro.”

“A Nikkiso poderá ajudar na realização deste projeto, bem como no fornecimento e manutenção de estações de abastecimento de hidrogênio líquido e GNL no mercado europeu”, disse Ole Jensen, Vice-Presidente da Europa. “Esta aquisição é um exemplo do nosso compromisso e apoio à meta da União Europeia de alcançar a neutralidade de carbono até 2050.”

A compra foi efetivada em 3 de fevereiro de 2023.

Nikkiso Clean Energy & Industrial Gases Group
O Nikkiso Clean Energy & Industrial Gases Group faz parte da Divisão Industrial da Nikkiso co. Lt. Japão. O Grupo opera nos EUA, sob a Cryogenic Industries, Inc. (membro da Nikkiso Co., Ltd.). As empresas membro do Grupo fabricam e prestam serviços para equipamentos de processamento de gás criogênico projetados (bombas, turboexpansores, trocadores de calor, etc.) e plantas de processamento de Gases Industriais, Liquefação de Gás Natural (GNL), Liquefação de Hidrogênio (LH2) e Ciclo Rankine Orgânico para Recuperação de Calor de Resíduos. Fundada há mais de 50 anos, a Cryogenic Industries é a empresa controladora da ACD, Nikkiso Cryo, Nikkiso Integrated Cryogenic Solutions, Cosmodyne e Cryoquip, e de um grupo comumente controlado de aproximadamente 20 entidades operacionais.

Para mais informação, visite www.NikkisoCEIG.com e www.nikkiso.com.

CONTATO COM A MÍDIA:
Anna Quigley
+1.951.383.3314
aquigley@cryoind.com

Foto deste comunicado disponível em:
https://www.globenewswire.com/NewsRoom/AttachmentNg/5818ee3c-2c93-4ad0-b03b-a87bda21cfce

GlobeNewswire Distribution ID 8744074

Carl D Francis takes the helm at medtech group focused on reversal of diabetes, NASH, and obesity

LONDON, Feb. 07, 2023 (GLOBE NEWSWIRE) — Today Keyron, the medical technology group focused on reversing type 2 diabetes, non-alcoholic steatohepatitis (NASH), and obesity via an innovative medical device platform, announced the appointment of Carl D Francis as Chief Executive Officer.

“The continuing rise in obesity, diabetes, and all forms of fatty liver disease is one of the biggest health challenges the world faces today. Literally billions of people are affected, and the numbers continue to rise rapidly,” Francis said. “Keyron’s technology is a complete game-changer. An innovative, non-surgical, endoscopically-delivered, fully reversible treatment as an alternative to drastic bariatric surgeries is as exciting as it gets. I am really proud and honoured to be part of Keyron.”

The American Diabetes Association states that today 37m Americans suffer from diabetes, with 96m having pre-diabetes. The link between obesity and diabetes is well established, and according to The World Obesity Federation’s forecast in their recently released 2022 Atlas, 67% of women and 51% of men in the Americas will be living with obesity (BMI ≥ 30) by 2030.

Keyron’s patented technology is designed to be a fully endoscopic, outpatient procedure providing the same or greater metabolic benefits of gastric bypass surgery, including a reversal of type 2 diabetes and obesity, as well as NASH and liver fibrosis.

Following successful rodent studies in 2019 and swine studies in 2022, Keyron’s first-in-human trials are planned to begin in early 2024. Keyron is targeting to achieve FDA clearance by 2028, and a US launch is planned as the first target market. The company is now making plans to raise a $15m Series A funding round.

Dr Giorgio Castagneto Gissey, Keyron’s Chairman, said, “We are thrilled that Carl will be leading Keyron as we enter this critical stage of our development. Carl brings energy, focus, and senior leadership experience to ensure we realize our full potential. Keyron has always had high profile, world-leading board members and medical advisors, and we continue to bring onboard remarkable people. We are truly delighted to have been able to attract Carl.”

Francis was previously CEO of successful nano-technology group P2i. During his tenure the group grew from a handful of employees to global leadership in the functional nano-coating space. He was most recently CEO of UK-based medtech group Eyoto which specializes in advanced technologies in the optical and ophthalmic industries. He started his career as a US CPA, is a member of Mensa, and has a BSc from the University of Cincinnati.

CONTACT

For further information please contact:

• In the USA – Carl D Francis at c.francis@keyron.com or +1 (912) 429-3800
• In Europe – Dr Giorgio Castagneto Gissey at gcgissey@keyron.com or +44 7975 911101

ABOUT KEYRON

Keyron is a UK-based, preclinical-stage medical device and technology platform company aimed at a highly-effective treatment of metabolic diseases. Keyron’s patented ForePass is an innovative medical device designed to safely reverse type-2 diabetes, as well as NASH, and obesity. The company has already demonstrated a full reversal of insulin resistance in animal studies, and recently published the results in The Lancet EBioMedicine. Keyron has upcoming clinical trials in South America and aims to then carry out further clinical trials in the USA. Its founders, directors, advisors and investors include some of the most well-known and cited professors and KOLs worldwide in the metabolic diseases space. The company is backed by multiple institutional investors based in the USA and EMEA.

GlobeNewswire Distribution ID 8743797